Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000724405 | SCV000229203 | uncertain significance | not provided | 2015-01-04 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000195005 | SCV000248668 | likely benign | not specified | 2016-01-08 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000724405 | SCV001838067 | benign | not provided | 2019-09-16 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000724405 | SCV002425132 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002336433 | SCV002638154 | likely benign | Inborn genetic diseases | 2022-05-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000724405 | SCV005074556 | likely benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | RAI1: BS1 |
Prevention |
RCV003917649 | SCV004736784 | likely benign | RAI1-related disorder | 2020-01-20 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |